Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

KRYSKRYS
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in Krystal Biotech, Inc.

NORTHERN TRUST CORP holds 283,784 shares of KRYS (Krystal Biotech, Inc.), worth $105.5M as of 2026-Q2. The position was increased (+12.4% shares). KRYS represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$105.5M

Current Shares

283,784

Total Value Change

+$62M

Total Shares Change

+45,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
283,784
+12.4%
$105.5M0.0%$371.67
34
2026-Q1
Increased
252,463
+2.0%
$65.2M0.0%$263.80
30
2025-Q4
Decreased
247,443
-0.3%
$61M0.0%$247.88
0
2025-Q3
Decreased
248,165
-1.3%
$43.8M0.0%$176.75
0
2025-Q2
Decreased
251,408
-3.3%
$34.6M0.0%$138.88
0
2025-Q1
Decreased
259,995
-0.9%
$46.9M0.0%$183.92
0
2024-Q4
Increased
262,263
+9.9%
$41.1M0.0%$159.80
32
2024-Q3
Increased
238,691
+9.3%
$43.4M0.0%$177.14
32

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used